Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000732485-05-000054
Filing Date
2005-07-22
Accepted
2005-07-22 09:46:28
Documents
1
Period of Report
2005-07-20

Document Format Files

Seq Description Document Type Size
1 wyz220.html 4  
1 wyz220.xml 4 8004
  Complete submission text file 0000732485-05-000054.txt   9715
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Issuer) CIK: 0000732485 (see all company filings)

EIN.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GENZYME CORP ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address
WYZGA MICHAEL S (Reporting) CIK: 0001201256 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14680 | Film No.: 05967565